Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 53, Issue 6, Pages 1931-1934Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.00649-15
Keywords
-
Categories
Funding
- bioMerieux (France)
- Actelion
- Cubist
- Astellas
- Merck
- Optimer
- Sanofi Pasteur
- AstraZeneca
- Durata
- Nabriva
- Novacta
- Pfizer
- Roche
- Basilea
- The Medicines Company
- VH Squared
- Cerexa
- Abbott
- bioMerieux
- Da Volterra
- European Tissue Symposium
Ask authors/readers for more resources
Prevention and management of Clostridium difficile infection (CDI) can be improved by rapid and reliable diagnostics. The Vidas C. difficile glutamate dehydrogenase assay had performance comparable to that of the Quik Chek-60 assay (overall agreement, 95%) and a sensitivity of >93%; thus, it is suitable as the first test in two-stage algorithms for a CDI diagnosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available